| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/17/2009 | EP2069520A2 Bifidobacterial gene sequences and their use |
| 06/17/2009 | EP2069490A2 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 06/17/2009 | EP2069481A2 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 06/17/2009 | EP1973429A4 Protein hydrolysates and method of making |
| 06/17/2009 | EP1957660A4 Materials and methods to increase peptide chain expression |
| 06/17/2009 | EP1937824A4 COMPOSITIONS OF tRNA AND USES THEREOF |
| 06/17/2009 | EP1602669B1 Antibody against a tumor-specific antigen as target |
| 06/17/2009 | EP1438400B1 Multi-chain eukaryotic display vectors and uses thereof |
| 06/17/2009 | EP1409544B1 Human dr4 antibodies and uses thereof |
| 06/17/2009 | EP1177304B1 Modified factor viia polypeptides |
| 06/17/2009 | EP1147211B1 High level expression of a heterologous protein having rare codons |
| 06/17/2009 | CN101457249A Method for preparing indissoluble aquatic collagen protein source ACE inhibitor peptides |
| 06/17/2009 | CN101457248A Method for preparing maillard flavor peptides by using soja bean separation protein |
| 06/17/2009 | CN101457247A Hybrid protein rapid enzymolysis method |
| 06/17/2009 | CN100500853C Fusion protein for secretion of protein of interest in supernatant of bacterial culture |
| 06/16/2009 | US7547820 Method for altering the nutritional content of plant seed |
| 06/16/2009 | US7547817 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/16/2009 | US7547770 Colostral fractionation process |
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547677 Peptide or fusion protein containing peptide binds to gut of sap-sucking insects, e.g., aphids; when bound, peptide inhibits binding of targeted virus to insect gut; when peptide is expressed in fluids of transgenic plants, is taken up by insect with sap, binds to gut receptors, inhibits transmission |
| 06/16/2009 | US7547662 Target recognizing binding agents |
| 06/16/2009 | US7547535 Mutant form of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (PQQ) monitoring glucose level in blood, serum and urine |
| 06/16/2009 | US7547531 L-amino acid producing microorganism which has been modified to inactive the fimH gene, and a method for producing I-amino acid |
| 06/16/2009 | US7547529 Formation of a by-product polypeptide containing an O-acetylserine residue in place of a serine residue by adding histidine, methionine or glycine to the medium in culturing transformed cells |
| 06/16/2009 | US7547528 Expression vector comprising nucleotide sequences coding coral fluorescent protein for use as reporter molecules in genetic engineering |
| 06/16/2009 | US7547518 Method of screening endothelial cells for angiogenic capability |
| 06/16/2009 | US7547509 Viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity, immunogenicity, improve pharmacokinetics, bioavailability; envelope viruses |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073163A1 Avian influenza antibodies, compositions, and methods thereof |
| 06/11/2009 | WO2009072660A1 Method for production of antibody |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072588A1 Monoclonal antibody responsive to mouse polymeric immunoglobulin receptor |
| 06/11/2009 | WO2009033047A3 Methods and compositions for treating diseases and conditions involving higher molecular weight hyaluronan |
| 06/11/2009 | WO2009027752A3 Process for producing hepcidin |
| 06/11/2009 | WO2007086879A3 Method of expressing proteins with disulfide bridges |
| 06/11/2009 | WO2007028106A3 Host cell lines for production of antibody constant region with enhanced effector function |
| 06/11/2009 | WO2003050137A3 Toll-like receptor 4 mutations |
| 06/11/2009 | WO2001098458A3 Methods for immobilizing polypeptides |
| 06/11/2009 | US20090151029 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/11/2009 | US20090151026 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
| 06/11/2009 | US20090151018 Gdc-1 genes conferring herbicide resistance |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090151011 Chimeric Non-Human Animal and Use Thereof |
| 06/11/2009 | US20090149637 Human antibodies derived from immunized xenomice |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/11/2009 | US20090149406 Plasmid PXL3179 or NV1FGF |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149374 Neuropeptides |
| 06/11/2009 | US20090149372 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders |
| 06/11/2009 | US20090149365 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090149310 millboard comprising aluminosilicate refractory fiber, said aluminosilicate refractory fiber, silicate, mica, kaolin clay, and cellulose; free of asbestos |
| 06/11/2009 | US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148925 Single chain class I major histocompatibility complexes |
| 06/11/2009 | US20090148908 Compositions and methods for generating antibodies |
| 06/11/2009 | US20090148907 Novel fructofuranosidase activity for obtaining the prebiotic oligosaccharide 6-kestose |
| 06/11/2009 | US20090148906 Optimized messenger rna |
| 06/11/2009 | US20090148905 Antigen-binding constructs |
| 06/11/2009 | US20090148904 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 06/11/2009 | US20090148903 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148902 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148901 Polypeptides having xylanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148900 Hemcm42 nucleic acids |
| 06/11/2009 | US20090148899 Method for producing optically-active amine compound, recombinant vector, and transformant containing the vector |
| 06/11/2009 | US20090148898 Human Ron-Related Gene Variant Associated With Cancers |
| 06/11/2009 | US20090148897 Human Ron-Related Gene Variant Associated With Cancers |
| 06/11/2009 | US20090148896 Hyperthermophilic DNA Polymerase and Methods of Preparation Thereof |
| 06/11/2009 | US20090148895 Method for Gene Amplification |
| 06/11/2009 | US20090148894 Methods for optimizing the secretion of protein in prokaryotes |
| 06/11/2009 | US20090148893 Novel Subtilases |
| 06/11/2009 | US20090148892 Novel methods |
| 06/11/2009 | US20090148891 Dna polymerases and related methods |
| 06/11/2009 | US20090148890 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/11/2009 | US20090148889 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148887 Genetically encoded boronate amino acid |
| 06/11/2009 | US20090148885 Fibroblast Growth Factor-Like Polypeptides |
| 06/11/2009 | US20090148874 improved specificity for glucose as compared to maltose; improve the thermostability, the specific activity and the affinity for glucose of an s-GDH mutant having a substitution at position 348 by selecting mutations from the positions; specific detection or measurement of glucose in biological samples |
| 06/11/2009 | US20090148601 Nanoloom for controlling polymer assembly |
| 06/11/2009 | US20090148513 Compositions and methods for crystallizing antibodies |
| 06/11/2009 | US20090148469 Multicomponent meningococcal vaccine |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148461 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148447 Binding Peptides Having a C-terminally Disposed Specific Binding Domain |
| 06/11/2009 | US20090148441 Anti-Cancer Antibodies With Reduced Complement Fixation |
| 06/11/2009 | US20090148436 Antibody to gdf8 and uses thereof |
| 06/11/2009 | US20090148405 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) receptor ligands |
| 06/11/2009 | US20090148403 Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use |
| 06/11/2009 | CA2707689A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |